INHIBRX, INC.

LA JOLLA, CA How do I update this listing?

Create Email Alert

Inhibrx is based out of La Jolla. Inhibrx, Inc. offers biologic therapeutics for people with life-threatening conditions. The Company focuses on developing a diverse pipeline of therapeutic candidates. Inhibrx serves customers worldwide.Whalewisdom has at least 4 13G filings The firm last filed a Form D notice of exempt offering of securities on 2020-04-16. The notice included securities offered of Equity,Debt,Option, Warrant or Other Right to Acquire Another Security,Security to be Acquired Upon Exercise of Option, Warrant or Other Right to Acquire Security

Contact Info

inhibrx, inc.
11025 N. TORREY PINES ROAD, SUITE 200
LA JOLLA CA    92037

Business Phone: (858) 795-4220
SEC SIC CODE:
2836-BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
Current 13D/G Holdings
Stock Sector Shares Held Market Value Rank Source Source Date
Inhibrx, Inc. (INBX) HEALTH CARE 3,188,998 71,050,875.44 1 13G 2021-12-31

Active Schedule 13D and 13G events

Sign in to see

Insider Transactions in the past year

Loading...

Form D Filings

Form D is a form to be used to file a notice of an exempt offering of securities with the Securities and Exchange Commission. Form D contains basic information about the offering and the company.

Form D Filings
Filing Date Form Type Industry Group Securities Offered Total Offering Amount Total Amount Sold Total Remaining
2020-04-16 D BIOTECHNOLOGY Equity,Debt,Option, Warrant or Other Right to Acquire Another Security,Security to be Acquired Upon Exercise of Option, Warrant or Other Right to Acquire Security 30,000,000 15,000,000 15,000,000
2019-05-31 D BIOTECHNOLOGY Equity,Debt,Option, Warrant or Other Right to Acquire Another Security,Security to be Acquired Upon Exercise of Option, Warrant or Other Right to Acquire Security 40,000,000 40,000,000 0
2018-05-11 D BIOTECHNOLOGY Equity 75,000,000 3,550,000 71,450,000
2018-05-10 D BIOTECHNOLOGY Equity 410,000,006 410,000,006 0
Other Issuers in Filings
Name Address
No Other Issuers
Related Parties included in filings
Name Address Relationship
MARK LAPPE subscription required
    EXECUTIVE OFFICER DIRECTOR
BRENDAN ECKELMAN subscription required
    DIRECTOR
JON FAIZ KAYYEM subscription required
    DIRECTOR
MARGERY FISCHBEIN subscription required
    DIRECTOR
DOUG FORSYTH subscription required
    DIRECTOR
JUDITH LI subscription required
    DIRECTOR
KELLY DECK subscription required
    EXECUTIVE OFFICER

Elevate your investments